Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Neuroendocrine Tumor
Regimen:
CAPOX (capecitabine + oxaliplatin)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
NCCN
Excerpt:
Pancreatic Neuroendocrine Tumors (Well-Differentiated Grade 1/2): Other Recommended Regimens...Cytotoxic chemotherapy options considered in patients with bulky, symptomatic, and/or progressive disease include:...CAPEOX (capecitabine + oxaliplatin).
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login